Sensorineural Hearing Loss After Chemoradiotherapy with High-Dose Cisplatin in Patients with Head and Neck Cancer
Objective: To investigate sensorineural hearing loss in patients with head and neck cancer receiving chemoradiotherapy (CRT) with a standard regimen of high-dose cisplatin (CDDP), focusing on the acute changes before and after CDDP administration during treatment.
Authors
- Kentaro Hori
- Mariko Kasuga
- Yutaka Takumi
- Yoh-ichiro Iwasa (ORCID: https://orcid.org/0000-0001-8989-9021)
- Kenzo Hirose (ORCID: https://orcid.org/0000-0001-8167-2690)
- Ryosuke Kitoh (ORCID: https://orcid.org/0009-0004-8123-1835)
Institutions
- Ōtani University (JP)
Publication Details
- Journal
- Practica Oto-Rhino-Laryngologica
- Published
- 2025-01-01
- DOI
- https://doi.org/10.5631/jibirin.118.683
- Primary Topic
- Vestibular and auditory disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00